Tylki-Szymanska, Anna <br/><br/>
Efficacy of recombinant human alpha-L-iduronidase (laronidase) on restricted range of motion of upper extremities in mucopolysaccharidosis type I patients.  [electronic resource] 

 -  Journal of inherited metabolic disease  Apr 2010 
 - 151-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1573-2665 
<br/><br/><label>Standard No.: </label>10.1007/s10545-010-9059-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Activities of Daily Living<br/>Adolescent<br/>Adult<br/>Arthrometry, Articular<br/>Child<br/>Child, Preschool<br/>Disease Progression<br/>Elbow Joint--drug effects<br/>Enzyme Replacement Therapy--methods<br/>Female<br/>Humans<br/>Iduronidase--therapeutic use<br/>Infant<br/>Male<br/>Movement--drug effects<br/>Mucopolysaccharidosis I--drug therapy<br/>Range of Motion, Articular--drug effects<br/>Recombinant Proteins--therapeutic use<br/>Self Care<br/>Shoulder Joint--drug effects<br/>Wrist Joint--drug effects<br/>Young Adult